According to the World Health
Organization (WHO), organ transplantation is often the last resort for
end-stage organ failure. Factors such as loss of blood, leukemia, drug abuse,
serious trauma, lack of exercise, and poisoning are resulting in increased occurrence
of organ failure. Thus, demand for transplantation products is anticipated to
surge in future.
Transplantation
of Organs or Tissues
Transplantation is a surgical
process in which an organ or tissue is removed from a donor’s body and moved to
a recipient’s body, to replace a missing or damaged organ or tissue. The donor
may be dead via circulatory death, may be brain dead, or may be living. Some of
the organs that have been successfully transplanted are kidneys, lungs,
intestine, heart, liver, thymus, and pancreas. Tissues transplanted thus far
include musculoskeletal grafts (bones and tendons), veins, nerves, heart
valves, and cornea.
Yale
Researchers Use Nanoparticles to Curtail Organ Rejection
Organ transplantation has
emerged as one of the most remarkable medical innovations. Rapid technological
advancements have enhanced the procedure’s efficiency and safety. However,
short-term and long-term organ rejection still remains an issue. To address it,
researchers are paying increased attention toward the development of innovative
techniques. A case in point is a team of researchers from Yale University. In
August 2017, the team developed a drug delivery system using nanoparticles.
This could curb organ transplant complications by camouflaging donated tissue
from the immune system of the recipient.
Besides this, researchers are
also focusing on development of artificial transplants with extra features that
can potentially benefit human life. For instance, in the same month,
researchers at the University of Chicago developed skin grafts using CRISPR
gene editing. This can help people with obesity and diabetes to better maintain
their glucose levels.
Market
Insights
As per the findings of Grand
View Research Inc., the global transplantation
market is estimated to USD 51.0 billion by 2025.
Technological advancements are expected to play an important role in the growth
of the market. Development of innovative and novel transplant products such as
surgical instruments and tissue products, along with increasing implementation
of computerized support systems, can work in favor of the market. Rising
incidence of chronic diseases and increasing number of tissue banks are also
likely to stoke market growth.
On the other hand, dearth of
donors for transplantation process is creating a large gap between demand and
supply of organs and tissues for treatment. This is, thereby, estimated to keep
the market from realizing its utmost potential. Moreover, customs and religious
beliefs are limiting widespread adoption of transplantations.
Some of the prominent companies
operating in the market are AbbVie, Inc.; Medtronic; Zimmer Biomet; Stryker;
Novartis AG; and Teva Pharmaceuticals.
In-Depth
research report on Transplantation Market:
No comments:
Post a Comment